表紙
市場調査レポート - 244191

止血:世界の治験動向

Hemostasis Global Clinical Trials Review, H1, 2015

発行 GlobalData
出版日 ページ情報 英文 93 Pages
電子版即納可
価格
Back to Top
止血:世界の治験動向 Hemostasis Global Clinical Trials Review, H1, 2015
出版日: 2015年06月25日 ページ情報: 英文 93 Pages
概要

当レポートでは、止血の治験 (臨床試験) に関する最新動向について分析しており、地域別の治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • 止血
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:血液疾患治療薬の治験における止血の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:血液疾患治療薬の治験における止血の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

止血治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Baxter International Inc.
    • 武田薬品工業
    • Johnson & Johnson
    • Novo A/S
    • Grifols, S.A.
    • ZymoGenetics, Inc. (Inactive)
    • The Medicines Company
    • LAL Clinica Pesquisa e Desenvolvimento Ltda
    • Teva Pharmaceutical Industries Limited
    • Omrix Biopharmaceuticals, Inc. (Inactive)
  • 代表的な研究機関・病院の治験の概要
    • Radboud University
    • Academic Medical Center
    • Austin Health
    • Azienda Ospedaliera Universitaria Senese
    • Azienda Unita Sanitaria Locale Lecce
    • Bassett Healthcare
    • Capital District Health Authority, Canada
    • Eidgenossische Technische Hochschule Zurich
    • Esbjerg Dentallaboratorium Aps
    • Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Hemostasis Global Clinical Trials Review, H1, 2015" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hemostasis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hemostasis to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hemostasis to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hemostasis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hemostasis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Novo A/S
      • Clinical Trial Overview of Novo A/S
      • Grifols, S.A.
      • Clinical Trial Overview of Grifols, S.A.
      • ZymoGenetics, Inc. (Inactive)
      • Clinical Trial Overview of ZymoGenetics, Inc. (Inactive)
      • The Medicines Company
      • Clinical Trial Overview of The Medicines Company
      • LAL Clinica Pesquisa e Desenvolvimento Ltda
      • Clinical Trial Overview of LAL Clinica Pesquisa e Desenvolvimento Ltda
      • Teva Pharmaceutical Industries Limited
      • Clinical Trial Overview of Teva Pharmaceutical Industries Limited
      • Omrix Biopharmaceuticals, Inc. (Inactive)
      • Clinical Trial Overview of Omrix Biopharmaceuticals, Inc. (Inactive)
    • Clinical Trial Overview of Top Institutes / Government
      • Radboud University
      • Clinical Trial Overview of Radboud University
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Austin Health
      • Clinical Trial Overview of Austin Health
      • Azienda Ospedaliera Universitaria Senese
      • Clinical Trial Overview of Azienda Ospedaliera Universitaria Senese
      • Azienda Unita Sanitaria Locale Lecce
      • Clinical Trial Overview of Azienda Unita Sanitaria Locale Lecce
      • Bassett Healthcare
      • Clinical Trial Overview of Bassett Healthcare
      • Capital District Health Authority, Canada
      • Clinical Trial Overview of Capital District Health Authority, Canada
      • Eidgenossische Technische Hochschule Zurich
      • Clinical Trial Overview of Eidgenossische Technische Hochschule Zurich
      • Esbjerg Dentallaboratorium Aps
      • Clinical Trial Overview of Esbjerg Dentallaboratorium Aps
      • Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
      • Clinical Trial Overview of Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hemostasis Therapeutics, Global, Clinical Trials by Region, 2015*
  • Hemostasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hemostasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hemostasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Hemostasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Hemostasis Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Hemostasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Hemostasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Hemostasis to Hematological Disorders Clinical Trials, G7 Countries (%), 2015*
  • Hemostasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hemostasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hemostasis to Hematological Disorders Clinical Trials, E7 Countries (%), 2015*
  • Hemostasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hemostasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hemostasis Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Hemostasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Hemostasis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hemostasis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hemostasis Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Hemostasis Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Hemostasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hemostasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Hemostasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hemostasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hemostasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by ZymoGenetics, Inc. (Inactive), 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medicines Company, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by LAL Clinica Pesquisa e Desenvolvimento Ltda, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Omrix Biopharmaceuticals, Inc. (Inactive), 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria Senese, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Unita Sanitaria Locale Lecce, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bassett Healthcare, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eidgenossische Technische Hochschule Zurich, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Esbjerg Dentallaboratorium Aps, 2015*
  • Hemostasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 2015*

List of Figures

  • Hemostasis Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Hemostasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hemostasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hemostasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Hemostasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Hemostasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Hemostasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Proportion of Hemostasis to Hematological Disorders Clinical Trials, G7 Countries (%), 2015*
  • Hemostasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hemostasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hemostasis to Hematological Disorders Clinical Trials, E7 Countries (%), 2015*
  • Hemostasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hemostasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hemostasis Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Hemostasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Hemostasis Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hemostasis Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hemostasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hemostasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Hemostasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hemostasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hemostasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top